CTLA4 and cancer: Forexample, antibodies engineered with high specificity against checkpoint inhibitorypathways of the T-cell protein, PD1, and cytotoxic T-lymphocyte associated protein-4(CTLA4) have led to revolutionary progress in cancer immunotherapy.8